This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
Since 2007, DaVita has raised millions and impacted thousands globally through annual activity-based events DENVER, Nov. 30, 2023 /PRNewswire/ — DaVita, a leading provider of kidney care…
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2023. “We delivered another strong quarter,” said Javier Rodriguez, CEO of DaVita Inc. “We…
Research includes studies designed to overcome barriers to living donation and in-home treatment among African American and Spanish-speaking Mexican American patients DENVER and PHILADELPHIA, Nov….
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time. The company plans…
DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes,…